Temporary plant shutdown for upgrades and new vial line

Capex & Operations View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-4.4%Reaction day

₹60.66

prior close

—

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.1%-4.5% vs market

Pharmaceuticals peers, median of 170sector+0.6%-5.0% vs sector

On the reaction day the stock moved 4.5 pts less than Nifty Microcap 250 and 5.0 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

—

10m

—

15m

—

30m

—

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-4.4+0.1-4.5+0.6-5.0

Next day

-5.2+0.7-5.9+1.1-6.4

-3.4pendingpending-0.1-3.4

—————

15d

—————

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 170Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Radiant Parenterals Limited, Rekvina Laboratories' wholly owned subsidiary, will temporarily close its manufacturing facility from October 28, 2026. The shutdown is planned for renovation, upgradation and installation of an additional vial manufacturing line. No project cost or duration was disclosed.

Likely market impact

Production will stop temporarily, which may weigh on near-term sales and earnings. Added capacity may support growth after the upgrade.